Literature DB >> 15202998

ARF1 regulates Nef-induced CD4 degradation.

Julien Fauré1, Romaine Stalder, Christelle Borel, Komla Sobo, Vincent Piguet, Nicolas Demaurex, Jean Gruenberg, Didier Trono.   

Abstract

BACKGROUND: The HIV Nef protein downregulates CD4 through sequential connection with clathrin-coated pits and the COP1 coatomer, resulting in accelerated endocytosis and lysosomal targeting.
RESULTS: Here we report that the small GTPase ARF1 controls the Nef-induced, COP-mediated late-endosomal targeting of CD4. We find that Nef binds ARF1 directly and can recruit the GTPase onto endosomal membranes. Furthermore, a complex comprising Nef, ARF1, and betaCOP can be immunoprecipitated from cells expressing the viral protein. Residues in a C-terminal loop of the viral protein facilitate both these interactions and the targeting of Nef and CD4 to acidic late endosomes, whereas other residues primarily involved in mediating CD4 endocytosis are dispensable for this process. Finally, a dominant-negative ARF1 mutant blocks the migration of the Nef-CD4 complex to lysosomes.
CONCLUSIONS: Our results support a model in which ARF1 is the immediate downstream partner of Nef for CD4 lysosomal targeting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202998     DOI: 10.1016/j.cub.2004.06.021

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  26 in total

1.  HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements.

Authors:  Jolie A Leonard; Tracy Filzen; Christoph C Carter; Malinda Schaefer; Kathleen L Collins
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

Review 2.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 3.  HIV immune evasion disruption of antigen presentation by the HIV Nef protein.

Authors:  Elizabeth R Wonderlich; Jolie A Leonard; Kathleen L Collins
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

4.  Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence.

Authors:  Andrey Tokarev; John Guatelli
Journal:  Cell Logist       Date:  2011-05

5.  ADP ribosylation factor 1 activity is required to recruit AP-1 to the major histocompatibility complex class I (MHC-I) cytoplasmic tail and disrupt MHC-I trafficking in HIV-1-infected primary T cells.

Authors:  Elizabeth R Wonderlich; Jolie A Leonard; Deanna A Kulpa; Kay E Leopold; Jason M Norman; Kathleen L Collins
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

Review 6.  Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways.

Authors:  Jeremiah F Roeth; Kathleen L Collins
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

7.  The Gcs1 Arf-GAP mediates Snc1,2 v-SNARE retrieval to the Golgi in yeast.

Authors:  Micah Robinson; Pak Phi Poon; Christina Schindler; Lois E Murray; Rachel Kama; Galina Gabriely; Richard A Singer; Anne Spang; Gerald C Johnston; Jeffrey E Gerst
Journal:  Mol Biol Cell       Date:  2006-02-01       Impact factor: 4.138

8.  A computational study of a recreated G protein-GEF reaction intermediate competent for nucleotide exchange: fate of the Mg ion.

Authors:  Mériam Ben Hamida-Rebaï; Charles H Robert
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

9.  Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression.

Authors:  Ravindra Pushker; Jean-Marc Jacqué; Denis C Shields
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

10.  Role of the second cysteine-rich domain and Pro275 in protein kinase D2 interaction with ADP-ribosylation factor 1, trans-Golgi network recruitment, and protein transport.

Authors:  Ganesh Varma Pusapati; Denis Krndija; Milena Armacki; Götz von Wichert; Julia von Blume; Vivek Malhotra; Guido Adler; Thomas Seufferlein
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.